About this journal

Aims and scope

This title has ceased (2017)

Aims & Scope: Launched in January 2012, JAK-STAT is the first international peer-reviewed journal to focus exclusively on the JAK-STAT signaling pathway.

JAK-STAT publishes full-length, original papers that feature findings on all aspects of mechanisms of actions in cellular signaling/transduction of the JAK-STAT pathways. A better understanding of the cellular and molecular mechanisms of JAK-STAT signaling pathways and their dysregulation in diseases may lead to new therapeutic approaches.

The journal has a prominent  Editorial Board made up of reputable scientists in the JAK-STAT field.

Journal Topics:

  • Transcription and regulation
  • Stem cell biology
  • Cell death, growth and development
  • Endocrinology and cellular metabolism
  • Cardiovascular biology, neuroscience biology
  • Infection and immunity, viral diseases
  • Cancer biology

Categories of manuscripts include:

  • Research papers/Reports
  • Perspectives/Reviews
  • Invited Special Focus topics
  • Commentaries

JAK-STAT offers online manuscript submission and peer-review by independent, anonymous expert referees, as well as a flexible open access policy. It is available in an online format.

Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106.

Sorry, there are currently no metrics available for this journal.

Abstracting and indexing

JAK-STAT is abstracted/indexed in:

  • Elsevier BV
    - EMBASE
  • National Library of Medicine
    - PubMed Central (PMC)

Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days
F1000Research. The Oncology Gateway. Accepting multiple article types. Submit now.